Evidence map›Paper›PMID 26714718›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2016

Improved Methods to Detect Low Levels of HIV Using Antibody-Based Technologies.

Eliseo A Eugenin, Joan W Berman

Abstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Eliseo A EugeninPublic Health Research Institute (PHRI), Rutgers University, 225 Warren Street, Newark, NJ, 07103, USA. eliseo.eugenin@rutgers.edu.
Joan W BermanDepartment of Pathology, The Albert Einstein College of Medicine, Jack and Pearl Resnick Campus, Forchheimer Building, Room 727, 1300 Morris Park Ave., Bronx, NY, 10461, USA. joan.berman@einstein.yu.edu.

Funding

Immunology/Pathology CoreP30AI051519 · NIAID · YESHIVA UNIVERSITY · PI GOLDSTEIN, HARRIS · 2003 to 2013
$18.6M
Astrocyte connexin43 containing channels amplify CNS dysfunction in NeuroAIDSR01MH096625 · NIMH · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI EUGENIN, ELISEO A · 2012 to 2020
$4.5M
Mechanisms of HAD:Role of CCL2 BBB & HIV InfectionR01MH075679 · NIMH · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI BERMAN, JOAN WEINBERGER · 2006 to 2016
$4.0M
Role of cellular prion protein in the pathogenesis of NeuroAIDSR01MH090958 · NIMH · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI BERMAN, JOAN WEINBERGER · 2011 to 2015
$1.9M
Mechanisms of HIV Tat regulation of macrophage gene expression in neuroAIDSR21MH102113 · NIMH · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI BERMAN, JOAN WEINBERGER · 2014 to 2015
$459k
NIAID NIH HHS AI-051519NIAID NIH HHS P30 AI051519NIMH NIH HHS MH075679NIMH NIH HHS MH090958NIMH NIH HHS MH096625NIMH NIH HHS MH102113NIMH NIH HHS R01 MH075679NIMH NIH HHS R01 MH090958NIMH NIH HHS R01 MH096625NIMH NIH HHS R21 MH102113
6 · The paper itself

Abstract

Persistence of latent virus represents a major barrier to eradicating HIV even in the current antiretroviral therapy era. A critical limitation to eliminating these viral reservoirs is the lack of reliable methods to detect, quantify, and characterize cells harboring low levels of virus. However, recent work of several laboratories indicates that PCR and viral amplification based technologies underestimate or overestimate the size of the reservoirs. Thus, new technologies and methodologies to detect, quantify, and characterize these viral reservoirs are necessary to monitor and eradicate HIV. Recent developments in imaging technologies have enabled the development or improvement of detection protocols and have facilitated the identification and quantification of several markers with exquisite resolution. In the context of HIV, we developed new protocols for the detection of low amounts of viral proteins. In this chapter, we describe several antibody-based technologies for signal amplification to improve and detect low amounts of HIV proteins in cells, tissues, and other biological samples. The improvement in these techniques is essential to detect viral reservoirs and to design strategies to eliminate them.

Indexed as

Virus LatencyBiotinylationEnzyme-Linked Immunosorbent AssayFluorescent DyesHistocytological Preparation TechniquesHIV-1HIV InfectionsHumansImmunoconjugatesMicroscopy, ConfocalViral ProteinsFluorescent DyesImmunoconjugatesViral ProteinsAIDSDetectionEradicationHIVQVOAReservoirs

Identifiers

PMID26714718
PMCPMC4762179

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.